Inhibition of transmembrane TNF-α shedding by a specific antibody protects against septic shock - Li, Chenxi; Gu, Haiyan; Yu, Mingxia; Yang, Peng; Zhang, Meng; Ba, Hongping; Yin, Yue; Wang, Jing; Yin, Bingjiao; Zhou, Xiaoxi; Li, Zhuoya (Cell death & disease, 2019)
Keywords: 13/1; 13/109; 13/21; 13/31; 13/95; 631/154/556; 631/250/127/1220; 631/250/2504/342; 631/250/256/1980; 631/250/262/2106/2108; 64/110; 64/60; 82/29; 82/80; Animals; Antibodies; Antibodies, Monoclonal - pharmacology; Antibodies, Monoclonal - therapeutic use; Biochemistry; Biodegradation; Biomedical and Life Sciences; Cecum; Cell Biology; Cell Culture; Cell Membrane - metabolism; Disease Models, Animal; Gene Knockout Techniques; HEK293 Cells; Humans; Immunology; Inflammation; Interferon; Interferon regulatory factor; Interferon regulatory factor 3; Interleukin 6; Internalization; Life Sciences; Lipopolysaccharides; Lipopolysaccharides - pharmacology; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Monoclonal antibodies; Monocytes; NIH 3T3 Cells; Nitric oxide; Protective Agents - pharmacology; Protective Agents - therapeutic use; RAW 264.7 Cells; Receptors, Tumor Necrosis Factor, Type I - genetics; Receptors, Tumor Necrosis Factor, Type II - genetics; Sepsis; Septic shock; Shock, Septic - chemically induced; Shock, Septic - drug therapy; THP-1 Cells; TLR4 protein; Toll-Like Receptor 4 - metabolism; Toll-like receptors; Transfection; Tumor Necrosis Factor-alpha - antagonists & inhibitors; Tumor Necrosis Factor-alpha - genetics; Tumor Necrosis Factor-alpha - metabolism; Tumor necrosis factor-α; β-Interferon